Multiple Sclerosis and Related Disorders - VJNeurology

Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Latest Videos Features Conferences NMOSD Videos MOGAD Videos Podcasts Expert Editorial Board

Welcome to The Multiple Sclerosis and Related Disorders Channel

In association with our Editorial Board, VJNeurology brings you the latest updates in multiple sclerosis and related disorders, directly from experts. As well as video interviews, you can listen to our podcasts or read our feature articles.

The Multiple Sclerosis and Related Disorders Channel brings you the latest advances in therapy, including novel immunotherapeutics and disease-modifying strategies, updates to diagnostic criteria, biomarker research, and more.

Latest Videos

View all

Phase II open-label extension of frexalimab in participants with relapsing multiple sclerosis

Phase II open-label extension of frexalimab in participants with relapsing multiple sclerosis

Patrick Vermersch • 24 Apr 2026

A digital tool to detect disability worsening in multiple sclerosis: the MS-DETECT study

A digital tool to detect disability worsening in multiple sclerosis: the MS-DETECT study

Patrick Vermersch • 24 Apr 2026

Advancing research and care in adult-onset genetic leukoencephalopathies

Advancing research and care in adult-onset genetic leukoencephalopathies

Holly Appleberry • 19 Apr 2026

Red flags for genetic demyelinating conditions and risks of misdiagnosing as MS

Red flags for genetic demyelinating conditions and risks of misdiagnosing as MS

Holly Appleberry • 19 Apr 2026

NMOSD and MOGAD channels

NMOSD

MOGAD

Conferences

AAN 2026

ACTRIMS 2026

ECTRIMS 2025

EAN 2025

AAN 2025

ECTRIMS 2024

NMOSD Videos

View all

Social determinants of health influence outcomes in pediatric NMOSD

Social determinants of health influence outcomes in pediatric NMOSD

Kelsey Poisson • 19 Apr 2026

Unmet needs and emerging therapies in pediatric NMOSD

Unmet needs and emerging therapies in pediatric NMOSD

Kelsey Poisson • 19 Apr 2026

Treatment of pediatric neuromyelitis optica spectrum disorder

Treatment of pediatric neuromyelitis optica spectrum disorder

Kelsey Poisson • 19 Apr 2026

The incidence and prevalence of AQP4+ NMOSD: data from a universal health insurance system

The incidence and prevalence of AQP4+ NMOSD: data from a universal health insurance system

Dalia Rotstein • 19 Feb 2026

MOGAD Videos

View all

Relationship between patient-reported outcomes, sociodemographic variables, and EDSS scores in MOGAD

Relationship between patient-reported outcomes, sociodemographic variables, and EDSS scores in MOGAD

Dalia Rotstein • 19 Feb 2026

Clinical presentation of MS, NMOSD, and MOGAD: differentiating between the three conditions

Clinical presentation of MS, NMOSD, and MOGAD: differentiating between the three conditions

Marcello Moccia • 2 Oct 2025

Including central vein sign in McDonald criteria to distinguish MS from similar diseases

Including central vein sign in McDonald criteria to distinguish MS from similar diseases

Celia Oreja-Guevara • 23 Jun 2025

Is there a prodromal phase in MOGAD or NMOSD?

Is there a prodromal phase in MOGAD or NMOSD?

Dalia Rotstein • 12 Mar 2024

Expert Editorial Board

mitzi-joi-williams

Mitzi Joi Williams

Joi Life Wellness Neurology Center

marcello-moccia

Marcello Moccia

University of Naples Federico II

celia-oreja-guevara

Celia Oreja-Guevara

University Hospital San Carlos and Complutense University of Madrid

If you are interested in becoming a supporter of The Multiple Sclerosis and Related Disorders Channel, please contact us.